R&D
Technology to Increase Selectivity for
cancer cells and Enhance Efficacy
Business Performance
  • HOME
  • R&D
  • Business Performance
PINOT-ADC™
  • Aptamer sciences
    2022.10

    ADC Platform
    (Total USD 1.24 bn)

  • aptamer group
    2022.06

    ADC Platform

NTX-301
  • AkiraBio
    2021.05

    Non-anticancer drug only(Rare blood disease)
    (Total USD 15mn)